ENGERIX B 10 susp inj enf (n ser pré) 0.5 ml

7680005510044 CH-551 J07BC01 08.08.
ENGERIX B 10 susp inj enf (n ser pré) 0.5 ml
ENGERIX B 10 susp inj enf (n ser pré) 0.5 ml
1 / 2
google

Details

Product number
0055103
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
hepatitidis B viri antigenum ADNr 10 µg, aluminium 0.25 mg ut aluminii hydroxidum, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.75 mg.

Articles (1)

Engerix-B 10, Injektionssuspension
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
0.25 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.75 MG Substance HBESI

Reimbursement information

Public price
CHF 39.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
551
Drug name
Engerix-B 10, Injektionssuspension
Galenic form
SUPA
ATC Code
J07BC01
Authorization status
Z
Dispensation category
B
First authorization
04/10/1989
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Hepatitis B, bei Neugeborenen, Kindern und Jugendlichen bis zum vollendeten 18. Lebensjahr

Packaging details

Description (FR)
ENGERIX B 10 susp inj enf (n ser pré) 0.5 ml
Description (DE)
ENGERIX B 10 Inj Susp Kind (n Fertspr) 0.5 ml
Market launch
01/05/2002
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

ENGERIX B 10 susp inj enf ser pré 0.5 ml
None None
View